Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma.
Saved in:
| Title: | Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma. |
|---|---|
| Authors: | Liebers N; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Boumendil A; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Finel H; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Edelmann D; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Baermann BN; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Serroukh Y; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Blaise D; Institut Paoli Calmettes, Marseille, France., Beelen DW; University Hospital Essen, Essen, Germany., Solano C; Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Itälä-Remes M; University Hospital Turku, Turku, Finland., van Meerten T; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Choi G; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schmidt SAC; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Kröger N; University Medical Center Hamburg, Hamburg, Germany., Byrne J; Nottingham University, Nottingham, United Kingdom., Tudesq JJ; CHU Lapeyronie, Montpellier, France., Ossami Saidy A; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Nunes A; Kite, a Gilead Company, Santa Monica, California., Siddiqi R; Kite, a Gilead Company, Santa Monica, California., Baro E; Kite, a Gilead Company, Santa Monica, California., Zheng D; Kite, a Gilead Company, Santa Monica, California., Kloos I; Kite, a Gilead Company, Santa Monica, California., Dreger P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Sureda A; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Clinical Hematology Department, Institut Català d'Oncologia-L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Glass B; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Dietrich S; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France. |
| Source: | Blood cancer discovery [Blood Cancer Discov] 2025 May 05; Vol. 6 (3), pp. 182-190. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
